Cite
HARVARD Citation
Caccese, M. et al. (2016). Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice. Expert opinion on pharmacotherapy. pp. 2253-2266. [Online].